Sonogen Medical, Inc.

Sonogen is working to commercialize a next-generation ultrasonic bone growth stimulation device proven to be 30% more effective in initial POC testing.

  • Stage Prototype Ready
  • Industry Medical Devices and Equipment
  • Location Chevy Chase, MD, USA
  • Currency USD
  • Founded March 2020
  • Employees 5
  • Incorporation Type C-corp
  • Website

Company Summary

Sonogen has developed an ultrasonic bone fracture diagnostics and healing device that heals 30% faster than the current standard of care. Our device will save patients $1B/year in lost wages, and payors $12B/year in avoided surgeries. This is a $3.6B total available market; we are 12 months from FDA submission. We have a lead investor and are looking for firms to syndicate; investors receive a 50% biotech investment rebate from the state of MD.


Previous Investors

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free